China removes quotas for foreign institutional investors under the QFII and RQFII schemes

文章 - 中国

(R)QFII: 5 things you need to know after removal of investment quota

We discuss 5 things you need to know after removal of investment quota under (R)QFII.

19 September 2019

China removes quotas for foreign institutional investors under the QFII and RQFII schemes

This week’s announcement continues a clear trend during 2019 of the Chinese Government seeking to attract additional foreign capital through investor-friendly reforms, including approval of the Foreign Investment 更多

16 September 2019

医药企业投资并购中的专利深度尽职调查

刚刚迈入2019年,医药企业投资并购领域就陆续迎来了数笔重大交易,如百时美施贵宝950亿美元并购新基制药,礼来80亿美元并购生物制药公司Loxo Oncology,武田制药620亿美元并购罕见病制药公司夏尔,以及罗氏48亿美元并购基因治疗研发公司Spark等。

2019/09/12

保险公司关联交易监管新规: 《保险公司关联交易管理办法》解读

为深入贯彻落实党中央、国务院在中央经济工作会议和全国金融工作会议上关于金融工作的有关精神

2019/09/12

CART免疫疗法的发展现状以及在中国的专利战场

2017年,两款CART产品(即,NH的Kymriah和KT的Yescarta)分别获得FDA的上市批准。

2019/09/12

U.S. Receives Comment Letters on Countervailing Duty Proposal

In June, we issued a client alert reporting on a Notice of Proposed Rulemaking that would allow the U.S. Department of Commerce (“Commerce”), under certain circumstances, to declare 更多

10 September 2019